Alnylam Pharmaceuticals
ALNY
#630
Rank
S$51.22 B
Marketcap
S$383.65
Share price
0.94%
Change (1 day)
8.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company